Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 94, Issue , 2015, Pages 532-541

  Lee, Jae Young ^a   Chung, Suk Jae ^a   Cho, Hyun Jong ^b   Kim, Dae Duk ^a  

^a Seoul National University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

CD44 receptor; Chondroitin sulfate A; Deoxycholic acid; Nanoparticles; Tumor targeting

Indexed keywords

CHONDROITIN 4 SULFATE; DEOXYCHOLIC ACID; DOXORUBICIN; HERMES ANTIGEN; NANOPARTICLE; ANTINEOPLASTIC ANTIBIOTIC; CHONDROITIN SULFATE; DRUG CARRIER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; LOADING DRUG DOSE; MOLECULARLY TARGETED THERAPY; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PH; PHYSICAL CHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; CHEMICAL PHENOMENA; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLISM; NUDE MOUSE; PARTICLE SIZE; SURFACE PROPERTY; SYNTHESIS; TUMOR CELL LINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD44; CELL LINE, TUMOR; CELL SURVIVAL; CHONDROITIN SULFATES; DEOXYCHOLIC ACID; DOXORUBICIN; DRUG CARRIERS; DRUG LIBERATION; FEMALE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; PARTICLE SIZE; SURFACE PROPERTIES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84937209212     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2015.06.011     Document Type: Article

References (43)

1. P. Cozzi, N. Mongelli, and A. Suarato Recent anticancer cytotoxic agents Curr. Med. Chem. Anticancer Agents 4 2004 93 121
2. E.D. Fleuren, Y.M. Versleijen-Jonkers, S. Heskamp, C.M. van Herpen, W.J. Oyen, W.T. van der Graaf, and O.C. Boerman Theranostic applications of antibodies in oncology Mol. Oncol. 8 2014 799 812
3. L. Gianni The future of targeted therapy: combining novel agents Oncology 63 2002 47 56
4. J. Lee, D. Jeong, S. Seo, and K. Na Biodegradable nanogel based on all-trans retinoic acid/pullulan conjugate for anti-cancer drug delivery J. Pharm. Invest. 43 2013 63 69
5. J.Y. Lee, J.S. Kim, H.J. Cho, and D.D. Kim Poly(styrene)-b-poly(DL-lactide) copolymer-based nanoparticles for anticancer drug delivery Int. J. Nanomed. 9 2014 2803 2813
6. J.H. Park, H.J. Cho, H.Y. Yoon, I.S. Yoon, S.H. Ko, J.S. Shim, J.H. Cho, J.H. Park, K. Kim, I.C. Kwon, and D.D. Kim Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery J. Control. Release 174 2014 98 108
7. U. Termsarasab, I.S. Yoon, J.H. Park, H.T. Moon, H.J. Cho, and D.D. Kim Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin Int. J. Pharm. 464 2014 127 134
8. F. Danhier, O. Feron, and V. Preat To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Control. Release 148 2010 135 146
9. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284
10. N. Bertrand, J. Wu, X. Xu, N. Kamaly, and O.C. Farokhzad Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology Adv. Drug Deliv. Rev. 66 2014 2 25
11. T. Lammers, F. Kiessling, W.E. Hennink, and G. Storm Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress J. Control. Release 161 2012 175 187
12. S. Ganesh, A.K. Iyer, D.V. Morrissey, and M.M. Amiji Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors Biomaterials 34 2013 3489 3502
13. H.Y. Yoon, H. Koo, K.Y. Choi, I. Chan Kwon, K. Choi, J.H. Park, and K. Kim Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery Biomaterials 34 2013 5273 5280
14. H.J. Cho, H.Y. Yoon, H. Koo, S.H. Ko, J.S. Shim, J.H. Cho, J.H. Park, K. Kim, I.C. Kwon, and D.D. Kim Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis J. Control. Release 162 2012 111 118
15. Y.J. Jin, U. Termsarasab, S.H. Ko, J.S. Shim, S. Chong, S.J. Chung, C.K. Shim, H.J. Cho, and D.D. Kim Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma Pharm. Res. 29 2012 3443 3454
16. N.S. Gandhi, and R.L. Mancera The structure of glycosaminoglycans and their interactions with proteins Chem. Biol. Drug Des. 72 2008 455 482
17. A. Pathak, P. Kumar, K. Chuttani, S. Jain, A.K. Mishra, S.P. Vyas, and K.C. Gupta Gene expression, biodistribution, and pharmacoscintigraphic evaluation of chondroitin sulfate-PEI nanoconstructs mediated tumor gene therapy ACS Nano 3 2009 1493 1505
18. C. Yu, C. Gao, S. Lu, C. Chen, J. Yang, X. Di, and M. Liu Facile preparation of pH-sensitive micelles self-assembled from amphiphilic chondroitin sulfate-histamine conjugate for triggered intracellular drug release Colloids Surf. B Biointerf. 115 2014 331 339
19. F. Li, and K. Na Self-assembled chlorin e6 conjugated chondroitin sulfate nanodrug for photodynamic therapy Biomacromolecules 12 2011 1724 1730
20. Y.S. Liu, C.C. Chiu, H.Y. Chen, S.H. Chen, and L.F. Wang Preparation of chondroitin sulfate-g-poly(epsilon-caprolactone) copolymers as a CD44-targeted vehicle for enhanced intracellular uptake Mol. Pharm. 11 2014 1164 1175
21. W. Park, S.J. Park, and K. Na Potential of self-organizing nanogel with acetylated chondroitin sulfate as an anti-cancer drug carrier Colloids Surf. B Biointerfaces 79 2010 501 508
22. Y. Hu, X. He, L. Lei, S. Liang, G. Qiu, and X. Hu Preparation and characterization of self-assembled nanoparticles of the novel carboxymethyl pachyman-deoxycholic acid conjugates Carbohydr. Polym. 74 2008 220 227
23. J. Li, M. Huo, J. Wang, J. Zhou, J.M. Mohammad, Y. Zhang, Q. Zhu, A.Y. Waddad, and Q. Zhang Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel Biomaterials 33 2012 2310 2320
24. K. Park, K. Kim, I.C. Kwon, S.K. Kim, S. Lee, D.Y. Lee, and Y. Byun Preparation and characterization of self-assembled nanoparticles of heparin-deoxycholic acid conjugates Langmuir 20 2004 11726 11731
25. H.J. Cho, I.S. Yoon, H.Y. Yoon, H. Koo, Y.J. Jin, S.H. Ko, J.S. Shim, K. Kim, I.C. Kwon, and D.D. Kim Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin Biomaterials 33 2012 1190 1200
26. O.B. Ijare, B.S. Somashekar, Y. Jadegoud, and G.A. Nagana Gowda, 1H and 13C NMR characterization and stereochemical assignments of bile acids in aqueous media Lipids 40 2005 1031 1041
27. U. Termsarasab, H.J. Cho, D.H. Kim, S. Chong, S.J. Chung, C.K. Shim, H.T. Moon, and D.D. Kim Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery Int. J. Pharm. 441 2013 373 380
28. T. Fujimoto, H. Kawashima, T. Tanaka, M. Hirose, N. Toyama-Sorimachi, Y. Matsuzawa, and M. Miyasaka CD44 binds a chondroitin sulfate proteoglycan, aggrecan Int. Immunol. 13 2001 359 366
29. W. Park, S.J. Park, and K. Na The controlled photoactivity of nanoparticles derived from ionic interactions between a water soluble polymeric photosensitizer and polysaccharide quencher Biomaterials 32 2011 8261 8270
30. J.N. Phillips The energetics of micelle formation Trans. Faraday Soc. 51 1955 561 569
31. H.Y. Yoon, H. Koo, K.Y. Choi, S.J. Lee, K. Kim, I.C. Kwon, J.F. Leary, K. Park, S.H. Yuk, J.H. Park, and K. Choi Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy Biomaterials 33 2012 3980 3989
32. N.V. Nukolova, H.S. Oberoi, S.M. Cohen, A.V. Kabanov, and T.K. Bronich Folate-decorated nanogels for targeted therapy of ovarian cancer Biomaterials 32 2011 5417 5426
33. J. Xi, L. Zhou, and H. Dai Drug-loaded chondroitin sulfate-based nanogels: preparation and characterization Colloids Surf. B Biointerf. 100 2012 107 115
34. K.Y. Choi, H.Y. Yoon, J.H. Kim, S.M. Bae, R.W. Park, Y.M. Kang, I.S. Kim, I.C. Kwon, K. Choi, S.Y. Jeong, K. Kim, and J.H. Park Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy ACS Nano 5 2011 8591 8599
35. H.S. Qhattal, T. Hye, A. Alali, and X. Liu Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes ACS Nano 8 2014 5423 5440
36. H.J. Cho, H.Y. Yoon, H. Koo, S.H. Ko, J.S. Shim, J.H. Lee, K. Kim, I.C. Kwon, and D.D. Kim Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic(R) for tumor-targeted delivery of docetaxel Biomaterials 32 2011 7181 7190
37. N. Afratis, C. Gialeli, D. Nikitovic, T. Tsegenidis, E. Karousou, A.D. Theocharis, M.S. Pavao, G.N. Tzanakakis, and N.K. Karamanos Glycosaminoglycans: key players in cancer cell biology and treatment FEBS J. 279 2012 1177 1197
38. R. Misra, and S.K. Sahoo Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy Eur. J. Pharm. Sci. 39 2010 152 163
39. S.R. Hwang, D.H. Seo, T.A. Al-Hilal, O.C. Jeon, J.H. Kang, S.H. Kim, H.S. Kim, Y.T. Chang, Y.M. Kang, V.C. Yang, and Y. Byun Orally active desulfated low molecular weight heparin and deoxycholic acid conjugate, 6ODS-LHbD, suppresses neovascularization and bone destruction in arthritis J. Control. Release 163 2012 374 384
40. W. Dai, F. Yang, L. Ma, Y. Fan, B. He, Q. He, X. Wang, H. Zhang, and Q. Zhang Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin alpha3 in triple-negative breast cancer Biomaterials 35 2014 5347 5358
41. J. Prados, C. Melguizo, R. Ortiz, C. Velez, P.J. Alvarez, J.L. Arias, M.A. Ruiz, V. Gallardo, and A. Aranega Doxorubicin-loaded nanoparticles: new advances in breast cancer therapy Anticancer Agents Med. Chem. 12 2012 1058 1070
42. P. Tassone, P. Tagliaferri, A. Perricelli, S. Blotta, B. Quaresima, M.L. Martelli, A. Goel, V. Barbieri, F. Costanzo, C.R. Boland, and S. Venuta BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells Br. J. Cancer 88 2003 1285 1291
43. J.E. Kim, I.S. Yoon, H.J. Cho, D.H. Kim, Y.H. Choi, and D.D. Kim Emulsion-based colloidal nanosystems for oral delivery of doxorubicin: improved intestinal paracellular absorption and alleviated cardiotoxicity Int. J. Pharm. 464 2014 117 126